Get the Stockscreener App
0.7614
1.25%
-0.0086
Longeveron Inc stock is traded at $0.7614, with a volume of 59,059.
It is down -1.25% in the last 24 hours and down -6.01% over the past month.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.
See More
Previous Close:
$0.77
Open:
$0.7634
24h Volume:
59,059
Relative Volume:
0.07
Market Cap:
$14.73M
Revenue:
$1.89M
Net Income/Loss:
$-17.92M
P/E Ratio:
-0.1138
EPS:
-6.69
Net Cash Flow:
$-15.62M
1W Performance:
-8.81%
1M Performance:
-6.01%
6M Performance:
-48.97%
1Y Performance:
-65.44%
1-Day Range:
$0.7524
$0.784
1-Week Range:
$0.7524
$0.8506
52-Week Range:
$0.633
$2.31
Longeveron Inc Stock (LGVN) Company Profile
Name
Longeveron Inc
Sector
Industry
Phone
305-302-7158
Address
1951 NW 7TH AVENUE, MIAMI
Compare LGVN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LGVN
Longeveron Inc
|
0.7524 | 16.43M | 1.89M | -17.92M | -15.62M | -6.69 |
|
VRTX
Vertex Pharmaceuticals Inc
|
411.46 | 105.61B | 11.74B | 3.68B | 3.50B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
643.74 | 67.99B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.20 | 58.19B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
846.68 | 52.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
185.06 | 39.60B | 447.02M | -1.18B | -906.14M | -6.1812 |
Longeveron Inc Stock (LGVN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-06-24 | Initiated | ROTH MKM | Buy |
Longeveron Inc Stock (LGVN) Latest News
Will Longeveron Inc. stock remain a Wall Street favorite2025 Market WrapUp & AI Based Buy and Sell Signals - newser.com
Longeveron Inc. (NASDAQ:LGVN) Q3 2025 Earnings Call Transcript - Insider Monkey
Why analysts upgrade Longeveron Inc. stockWeekly Trend Summary & Free Expert Approved Momentum Trade Ideas - newser.com
What dividend safety score for Longeveron Inc. stockWeekly Profit Analysis & Safe Entry Zone Identification - newser.com
What data driven models say about Longeveron Inc.’s futureJuly 2025 Trends & Risk Managed Investment Signals - newser.com
Can you recover from losses in Longeveron Inc.Weekly Stock Recap & Daily Profit Maximizing Tips - newser.com
Visualizing Longeveron Inc. stock with heatmapsTrade Volume Report & Scalable Portfolio Growth Methods - newser.com
Longeveron Inc. Earnings Call: Mixed Sentiments Amid Clinical Progress - TipRanks
Key facts: Longeveron anticipates pivotal trial results in 2026; Q3 expenses at $7.435M - TradingView
Longeveron Inc. Reports Q3 2025 Financial Results - TipRanks
Transcript : Longeveron Inc., Q3 2025 Earnings Call, Nov 04, 2025 - MarketScreener
Longeveron Posts Bigger Losses But Analysts Still See Upside - Finimize
Earnings call transcript: Longeveron Q3 2025 revenue drops, stock declines By Investing.com - Investing.com Canada
Longeveron reports Q3 EPS (39c), consensus (26c) - TipRanks
Cellular therapy developer Longeveron's Q3 net loss widens - MarketScreener
Longeveron® Announces Third Quarter 2025 Financial Results and Provides Business Update - The Manila Times
[8-K] Longeveron Inc. Reports Material Event | LGVN SEC FilingForm 8-K - Stock Titan
Is Longeveron Inc. stock in correction or buying zoneJuly 2025 Earnings & Reliable Volume Spike Alerts - newser.com
Longeveron Inc. (LGVN) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Longeveron Inc. (LGVN) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Earnings To Watch: Longeveron Inc (LGVN) Reports Q3 2025 Result - GuruFocus
Is it too late to sell Longeveron Inc.July 2025 Outlook & Daily Growth Stock Investment Tips - newser.com
How to recover losses in Longeveron Inc. stockCEO Change & Long-Term Capital Growth Strategies - newser.com
What analysts say about Longeveron Inc stockBullish Engulfing Patterns & Free Dashboard to Track Market Momentum - earlytimes.in
How Longeveron Inc. stock compares to growth peersPortfolio Value Report & Proven Capital Preservation Methods - fcp.pa.gov.br
Will Longeveron Inc. stock continue dividend increasesWeekly Trade Analysis & Low Drawdown Momentum Ideas - newser.com
Longeveron Inc Stock (LGVN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Longeveron Inc Stock (LGVN) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Soffer Rock | Director |
May 29 '25 |
Sale |
1.30 |
10,000 |
13,000 |
220,034 |
3.48%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):